Ted Driscoll, PhD
Ted Driscoll brings 30 years of experience in health and imaging technology as an investor and entrepreneur. Ted is an expert on digital health and diagnostics, from big data and health technology to genomics and personalized medicine.
Ted has a successful track record of sourcing and leading the financing of promising digital healthcare startup companies, including Natera, GeneWeave and Numedii. Ted currently represents CCV on the boards of Natera, AssureX, Numedii, Zipline Medical, GeneWeave BioSciences, Prime Genomics and Gigagen. He also served as a board member of Tibion (acquired by AlterG).
Prior to Claremont Creek, Ted founded five successful companies in imaging-related markets. He was founder and CEO of Be Here Technologies, a pioneer in Internet, Broadcast and Videoconferencing technologies. He also served as CEO of Focus Surgery, spun off from Diasonics, and was previously Division President and CTO of Diasonics, with responsibility for its MRI, ultrasound, digital X-ray, and ablation technology business. Earlier, he led the Diasonics team that developed the first commercial MRI scanners. Previously, Ted was also Vice President of Engineering at Identix, then a world leader in fingerprint recognition; and was Director of R&D at International Imaging Systems, an early pioneer in satellite remote sensing.
Ted was an angel investor with Life Science Angels and a founding director of the Sand Hill Angels and Health Tech Capital. Ted holds a PhD from Stanford University in Digital Imaging, Masters degrees from Harvard University in Computer Graphics and Remote Sensing and a Bachelor's degree from the University of Pennsylvania. Ted holds 40+ granted US and foreign patents in imaging-related fields.
Alter G (formerly Tibion)